Overview

Actively managed equity portfolio investing worldwide in companies from the health transformation sector.

Efficient means of exploiting the potential of companies operating in the health Transformation area.

Specialised sector analysts seek out the attractive stocks in the Health Transformation area.

Investment decisions are based on a disciplined investment philosophy and fundamental research.

This fund promotes environmental, social and corporate governance characteristics. The research and portfolio construction processes incorporate ESG risk integration and screening and comply with 麻豆社 Asset Management Sustainability exclusion policy. For more information on Sustainability at 麻豆社, please refer to www.ubs.com/am-si-commitment.

The portfolio manager is not tied to the benchmark in terms of investment selection or weight.

Benefits

The fund is pairing CIO identified investment themes with the stock selection and portfolio construction expertise of 麻豆社 Asset Management.

The fund taps into the knowledge of proven sector specialists.

麻豆社’s proprietary fundamental valuation approach allows consistent identification of the most attractive global health transformation companies.

Investors benefit from a global investment platform of 麻豆社 Asset Management.

Risks

麻豆社 Sector Funds invest in equities and may therefore be subject to high fluctuations in value. As these 麻豆社 Funds pursue an active management style, each Fund's performance can deviate substantially from that of its reference index. Focusing intentionally on individual sectors may entail additional risks. Sustainability risks are environmental, social or governance events or conditions that can have a material negative effect on the return, depending on the relevant sector, industry and company exposure. Sustainability risk: the risk arising from any environmental, social or governance events or conditions that, were they to occur, could cause a material negative impact on the value of the investment. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.

Features

Product category
麻豆社 Equity Funds
麻豆社 Sector Funds
Product domicile
Luxembourg
Portfolio management
麻豆社 Asset Management (Americas) LLC, New York
Fund management
麻豆社 Asset Management (Europe) S.A., Luxembourg
Custodian bank
麻豆社 Europe SE, Luxembourg Branch
Representative for products established under foreign law
麻豆社 AG, Stockholm
Day of inception
November 24, 2021
Currency of account
USD
Currency of unit class
EUR
Close of financial year
November 30
SFDR Classification
Art.8
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
1.05% p.a.
Management fee
0.77% p.a.
Total expense ratio (TER)
1.04% p.a.
Swing pricing
yes
Minimum investment
n.a.
Reference Index / Benchmark
MSCI World Health Care (net div. reinv.) (hedged EUR)
ISIN
LU2402148733
Bloomberg Ticker
UBHCHQA LX

Performance and Prices

Percentage growth

as of May 27, 2026
Cumulative
EUR(%)
YTD
1M
3M
6M
1Y 20.80
2Y
3Y 26.06
5Y -
ø p.a.5Y

Current data

Net asset value 27.05.2026 EUR 114.41
High - last 12 months 27.02.2026 EUR 120.54
Low - last 12 months 08.08.2025 EUR 94.23
Assets of the unit class in mn 27.05.2026 EUR 7.54
Total product assets in mn 27.05.2026 EUR 228.38
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 30.04.2026 13.50% n.a.
Sharpe Ratio 30.04.2026 0.32 n.a.
Risk Free Rate 30.04.2026 2.67% 1.93%

Structures

Fees

Ongoing costs p.a.
1.05%
Flat fee
0.96%
Management fee p.a.
0.77%
Max. issuing commission
5.00%
Max. redemption commission
0.00%
Distribution fee
(see info)

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Austria
Registered
Chile
Institutional Only*
Denmark
Registered
Finland
Registered
Germany
Registered
Greece
Registered
Italy
Institutional Only*
Liechtenstein
Registered
Luxembourg
Registered
Netherlands
Registered
Norway
Registered
Singapore
Institutional Only*
Spain
Registered
Sweden
Registered
Switzerland
Registered
United Kingdom
Registered

Literature

Agreement / Prospectus
Document type
Document Language
Prospectus
Country supplement
Key Information Document
Past performance
Previous performance scenario
Statutes / Management regulations
Annual and semi-annual report (accounting on November 30)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.